A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Commission approves Jannsen's CARVYKTI ciltacabtagene autoleucel cilta-cel for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy; it is the first BCMA-targeted treatment approved by the EC

HI SCR81: Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To ...

INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "TREATMENT OF LUPUS"

FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease

Health Canada approves Merck & Co's KEYTRUDA in combination with chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma treatment following successful Phase 3 trial

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count